Margaret Koziel - Feb 8, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
Chief Medical Officer
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 04:57 PM
Previous filing
Dec 13, 2021
Next filing
Mar 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +33.4K $0.00 33.4K Feb 8, 2022 Common Stock 33.4K $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.